ArticleJournal of pain research2026
Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Randomized Controlled Trial.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07253194 (Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer： A Randomized Controlled Trial), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer： A Randomized Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Postoperative urinary retention (POUR) is a prevalent complication following radical surgery for cervical cancer, significantly impairing patients' quality of life. Electroacupuncture (EA) has shown potential benefits in alleviating POUR symptoms. However, its efficacy in some specific clinical contexts remains to be systematically evaluated. Methods and Analysis: This is a prospective, single-blinded, single-center, randomized controlled trial designed to compare the efficacy of EA versus sham EA for POUR after radical cervical cancer surgery. A total of 208 patients with POUR after radical hysterectomy for cervical cancer will be randomly allocated to the EA group or the sham EA group at a 1:1 ratio. Participants in the EA group will receive EA treatment at a frequency of 5 sessions per week for 2 weeks, while those in the sham EA group will undergo sham EA interventions on the same schedule. The primary outcome will be the response rate of participants with successful urinary catheter removal. Secondary outcomes will include the changes in post-void residual (PVR) volume, assessment of urinary tract infection (UTI), and quality of life assessment according to the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30) scale. All analyses will be conducted in accordance with the intention-to-treat principle. Ethics/Dissemination: This study protocol was approved by the Medical Ethics Committee of Zhejiang Cancer Hospital on 20 October 2025 (approval number: IRB-2025-1315). The trial will evaluate the clinical efficacy and safety of EA on POUR after radical hysterectomy for cervical cancer. Results will be disseminated to the medical community through peer-reviewed publications and conference presentations to inform clinical practice. Trial Registration: Registered on ClinicalTrials.gov with the identification number of NCT07253194 (https://register.clinicaltrials.gov/, 28 November 2025).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.